Liza Villaruz, Md

This study tested a combination of two immunotherapy drugs (tiragolumab and atezolizumab) in people with a type of lung cancer that had spread to the brain but wasn't causing symptoms. The goal was to see if the treatment could control the brain tumors and delay the need for radi…